Other Technology, Media and Telecommunications Inpharmatica obtains £31.25m funding from equity investors Dresdner Kleinwort Wasserstein, Advent Venture Partners and 3i. By The Lawyer 30 July 2001 00:00 14 December 2015 05:45 Inpharmatica advised by Linklaters & Alliance (Jon Hayes). 3i and 3i Biosciences Investment Trust advised by Osborne Clarke (Alisdair Livingstone). Syndicate of investors advised by SJ Berwin (Perry Yam). Name Email Cancel reply Threaded commenting powered by interconnect/it code.